We also evaluated the relationship of this expression with the clinical characteristics, expression of E-cadherin, N-cadherin, and vimentin, and prognosis to determine whether the level of Gli2 expression could be used to predict prognosis in patients with HCC after radical hepatectomy. This evidence concerns the gene GLI2 and hepatocellular carcinoma.